AS Latvijas Juras medicinas centrs (RSE: LJM1R)
Latvia
· Delayed Price · Currency is EUR 6.50
-0.30 (-4.41%)
At close: Dec 17, 2024
RSE: LJM1R Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 10.2 | 9.85 | 9.7 | 9.36 | 7.08 | 7.27 | Upgrade
|
| Revenue Growth (YoY) | 6.02% | 1.54% | 3.60% | 32.24% | -2.62% | 8.95% | Upgrade
|
| Cost of Revenue | 9.25 | 9.08 | 8.53 | 7.77 | 6.18 | 6.44 | Upgrade
|
| Gross Profit | 0.95 | 0.77 | 1.17 | 1.6 | 0.9 | 0.83 | Upgrade
|
| Selling, General & Admin | 0.69 | 0.67 | 0.71 | 0.58 | 0.56 | 0.59 | Upgrade
|
| Other Operating Expenses | 0.47 | 0.17 | -0.17 | 0.14 | 0.07 | 0.08 | Upgrade
|
| Operating Expenses | 1.16 | 0.84 | 0.54 | 0.72 | 0.63 | 0.67 | Upgrade
|
| Operating Income | -0.21 | -0.07 | 0.63 | 0.88 | 0.27 | 0.17 | Upgrade
|
| EBT Excluding Unusual Items | -0.21 | -0.07 | 0.63 | 0.88 | 0.27 | 0.17 | Upgrade
|
| Asset Writedown | -0.55 | -0.55 | - | - | - | - | Upgrade
|
| Pretax Income | -0.76 | -0.62 | 0.63 | 0.88 | 0.27 | 0.17 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Earnings From Continuing Operations | -0.76 | -0.62 | 0.63 | 0.88 | 0.27 | 0.16 | Upgrade
|
| Net Income | -0.76 | -0.62 | 0.63 | 0.88 | 0.27 | 0.16 | Upgrade
|
| Net Income to Common | -0.76 | -0.62 | 0.63 | 0.88 | 0.27 | 0.16 | Upgrade
|
| Net Income Growth | - | - | -28.92% | 221.79% | 66.64% | - | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| EPS (Basic) | -0.95 | -0.78 | 0.78 | 1.10 | 0.34 | 0.21 | Upgrade
|
| EPS (Diluted) | -0.95 | -0.78 | 0.78 | 1.10 | 0.34 | 0.21 | Upgrade
|
| EPS Growth | - | - | -28.92% | 221.79% | 66.64% | - | Upgrade
|
| Free Cash Flow | 0.04 | -0.57 | 0.46 | -0.69 | 0.22 | 0.22 | Upgrade
|
| Free Cash Flow Per Share | 0.05 | -0.71 | 0.58 | -0.86 | 0.27 | 0.28 | Upgrade
|
| Dividend Per Share | - | - | - | 0.200 | 0.070 | - | Upgrade
|
| Dividend Growth | - | - | - | 185.71% | - | - | Upgrade
|
| Gross Margin | 9.31% | 7.83% | 12.05% | 17.07% | 12.78% | 11.46% | Upgrade
|
| Operating Margin | -2.04% | -0.74% | 6.46% | 9.41% | 3.88% | 2.27% | Upgrade
|
| Profit Margin | -7.46% | -6.34% | 6.45% | 9.40% | 3.86% | 2.26% | Upgrade
|
| Free Cash Flow Margin | 0.41% | -5.75% | 4.78% | -7.39% | 3.07% | 3.06% | Upgrade
|
| EBITDA | 0.42 | 0.48 | 1.05 | 1.17 | 0.51 | 0.36 | Upgrade
|
| EBITDA Margin | 4.08% | 4.86% | 10.87% | 12.47% | 7.19% | 4.98% | Upgrade
|
| D&A For EBITDA | 0.62 | 0.55 | 0.43 | 0.29 | 0.23 | 0.2 | Upgrade
|
| EBIT | -0.21 | -0.07 | 0.63 | 0.88 | 0.27 | 0.17 | Upgrade
|
| EBIT Margin | -2.04% | -0.74% | 6.46% | 9.41% | 3.88% | 2.27% | Upgrade
|
| Effective Tax Rate | - | - | 0.10% | 0.07% | 0.39% | 0.57% | Upgrade
|
| Advertising Expenses | - | 0.02 | 0.01 | 0 | 0 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.